IDEAS home Printed from https://ideas.repec.org/a/nat/natcom/v16y2025i1d10.1038_s41467-025-59432-8.html
   My bibliography  Save this article

Structure-based design of potent and selective inhibitors targeting RIPK3 for eliminating on-target toxicity in vitro

Author

Listed:
  • Haixia Su

    (University of Chinese Academy of Sciences
    University of Chinese Academy of Sciences)

  • Guofeng Chen

    (University of Chinese Academy of Sciences)

  • Hang Xie

    (Nanjing University of Chinese Medicine)

  • Wanchen Li

    (University of Nottingham Ningbo China)

  • Muya Xiong

    (University of Chinese Academy of Sciences)

  • Jian He

    (University of Chinese Academy of Sciences
    University of Chinese Academy of Sciences)

  • Hangchen Hu

    (University of Chinese Academy of Sciences)

  • Wenfeng Zhao

    (University of Chinese Academy of Sciences)

  • Qiang Shao

    (University of Chinese Academy of Sciences
    University of Chinese Academy of Sciences)

  • Minjun Li

    (Chinese Academy of Sciences)

  • Qiang Zhao

    (University of Chinese Academy of Sciences
    University of Chinese Academy of Sciences
    Nanjing University of Chinese Medicine)

  • Yechun Xu

    (University of Chinese Academy of Sciences
    University of Chinese Academy of Sciences
    University of Chinese Academy of Sciences)

Abstract

The essential role of RIPK3 in necroptosis makes its inhibition a promising therapeutic strategy. However, the development of RIPK3 inhibitors has been hampered by on-target apoptosis and limited kinase selectivity. Inspired by the R69H mutation, which prevents on-target apoptosis by disrupting RIPK3 dimerization, we design LK-series inhibitors that effectively inhibit RIPK3 in biochemical assays and block TNF-α-induced necroptosis in both mouse L929 and human HT29 cells without inducing apoptosis. The representative compound, LK01003, shows high selectivity across a panel of 379 kinases. Our structural studies reveal that LK compounds act as Type I1/2 inhibitors, engaging a unique hydrophobic site and stabilizing an inactive conformation of RIPK3. Moreover, several type II inhibitors are also revealed to maintain RIPK3 in the inactive conformation and do not induce on-target apoptosis. These findings suggest a promising strategy for rational design of safe and selective inhibitors by locking the inactive conformation of RIPK3.

Suggested Citation

  • Haixia Su & Guofeng Chen & Hang Xie & Wanchen Li & Muya Xiong & Jian He & Hangchen Hu & Wenfeng Zhao & Qiang Shao & Minjun Li & Qiang Zhao & Yechun Xu, 2025. "Structure-based design of potent and selective inhibitors targeting RIPK3 for eliminating on-target toxicity in vitro," Nature Communications, Nature, vol. 16(1), pages 1-15, December.
    • Handle: RePEc:nat:natcom:v:16:y:2025:i:1:d:10.1038_s41467-025-59432-8
    DOI: 10.1038/s41467-025-59432-8
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/s41467-025-59432-8
    File Function: Abstract
    Download Restriction: no
    File URL: https://libkey.io/10.1038/s41467-025-59432-8?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:16:y:2025:i:1:d:10.1038_s41467-025-59432-8. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.